Use of Cannabinoids for the Treatment of OSA
- 16 November 2020
- journal article
- research article
- Published by Springer Nature in Current Sleep Medicine Reports
- Vol. 6 (4) , 226-231
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Respiratory Physiology During SleepSleep Medicine Clinics, 2012
- Non-CPAP therapies in obstructive sleep apnoeaEuropean Respiratory Journal, 2011
- Circulating Endocannabinoids and N-acyl-ethanolamides in Patients with Sleep Apnea – Specific Role of OleoylethanolamideExperimental and Clinical Endocrinology & Diabetes, 2010
- The contribution of VR1 and CB1 receptors and the role of the afferent vagal pathway in modelling of cardio-respiratory effects of anandamide in ratsLife Sciences, 2007
- The pharmacology of cannabinoid receptors and their ligands: an overviewInternational Journal of Obesity, 2006
- Identification and Functional Characterization of Brainstem Cannabinoid CB2ReceptorsScience, 2005
- Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brainNeuroscience, 1997
- Molecular characterization of a peripheral receptor for cannabinoidsNature, 1993
- Serotonergic excitatory drive to hypoglossal motoneurons in the decerebrate catNeuroscience Letters, 1992
- Response of Obstructive Sleep Apnea to Fluoxetine and ProtriptylineChest, 1991